SGLT2 Inhibitors Curb AF Post-Ablation Recurrences in T2D
Retrospective, observational data from more than 13,000 US patients with type 2 diabetes and atrial fibrillation suggest that SGLT2 inhibitor treatment may cut AF recurrences post-ablation.
Medscape Medical News
source https://www.medscape.com/viewarticle/995415?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/995415?src=rss
Comments
Post a Comment